Chronic GVHD and donor genotype
| Genotype . | Chronic GVHD . | ||
|---|---|---|---|
| None . | Present . | Percent . | |
| DIFNγIntron1 genotype | |||
| DIFNγIntron1-3/3 | 5 | 5 | 50.0 |
| DIFNγIntron1-2/3 | 8 | 12 | 60.0 |
| DIFNγIntron1-2/2 | 6 | 3 | 33.3 |
| DIFNγIntron1-Other | 7 | 4 | 36.4 |
| DIL-6−174genotype | |||
| DIL-6−174GG | 5 | 10 | 66.7 |
| DIL-6−174GC | 13 | 7 | 35.0 |
| DIL-6−174CC | 9 | 6 | 40.0 |
| Genotype . | Chronic GVHD . | ||
|---|---|---|---|
| None . | Present . | Percent . | |
| DIFNγIntron1 genotype | |||
| DIFNγIntron1-3/3 | 5 | 5 | 50.0 |
| DIFNγIntron1-2/3 | 8 | 12 | 60.0 |
| DIFNγIntron1-2/2 | 6 | 3 | 33.3 |
| DIFNγIntron1-Other | 7 | 4 | 36.4 |
| DIL-6−174genotype | |||
| DIL-6−174GG | 5 | 10 | 66.7 |
| DIL-6−174GC | 13 | 7 | 35.0 |
| DIL-6−174CC | 9 | 6 | 40.0 |
The number of donors possessing each cytokine genotype is shown with occurrence of cGVHD in the corresponding patient and the percentage with cGVHD.
D indicates donor.